Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

FDA Approvals

US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

Drug Development
The U.S. Food and Drug Administration has granted approval to Johnson & Johnson’s drug delivery system for a specific type of bladder cancer. The...

FDA Approves Recombinant VWF Treatment in Pediatric Patients

Drug Development
The US Food and Drug Administration (FDA) has expanded the indication for recombinant von Willebrand factor (VWF), marketed as Vonvendi, to include children with...

FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

Americas
Eisai has achieved an important regulatory milestone as the FDA approves Leqembi IQLIK, strengthening the company’s long-term plans to expand the medicine’s use in...

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

Americas
The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...

U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

FDA Approvals
Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for DAWNZERA™ (donidalorsen). The treatment is approved for prophylaxis to...

The U.S. FDA Approved Papzimeos for RRP Treatment in Adults

Americas
The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral vector-based immunotherapy for adult...

FDA Approves Brinsupri by Insmed for Chronic Lung Condition

Americas
The U.S. Food and Drug Administration, FDA approves Brinsupri, Insmed's oral drug for a lung disease, the company announced. This marks the first treatment...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

System

Resources

Subscribe

© 2025 Copyright © Valuemediaservices 2025 All rights reserved.